ImmunityBio, Inc. — Balance Sheet Charts
10 snapshots of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Debt Structure
Working Capital Components
Total Assets
$502M
Current Assets
$315M
Cash & Equivalents
$88M
ST Investments
$154M
Receivables
$43M
Inventory
$910K
Net PPE
$114M
Goodwill
$910K
Intangibles
$13M
Total Liabilities
$1.00B
Current Liabilities
$62M
Account Payables
—
Short-Term Debt
$2M
Stockholders Equity
$-500M
Retained Earnings
$-3.73B
Operating Lease ROU Asset
$33M
Operating Lease Liability↑+6730.3% +$40M
$41M
Finance Lease ROU Asset
$271K
Gross PP&E
$227M
Accumulated Depreciation
$112M
Inventory Raw Materials
$0
Inventory WIP
$13M
Inventory Finished Goods
$2M
Contract Liability
—